MENA Region Landscape

Pharma Business Size*

  • Biggest MKT (KSA 28%, EGY 21%,
    S.Afr 12% & UAE 9%).
  • FWA with fastest growth 16% PPG.

Rare & Orphan Diseases *

  • Est. globally there are 5000-8000 orphan disease that have been identified with only 1500 identified includes (Sickle Cell Disease, Thalassemia, Hemophilia, certain inborn errors of metabolism (Pompe’s disease, Mucopolysaccharidosis types) and Bechet’s disease.
  • EST. 2.97 Million patients in the MENA region

By 2025, MENA pharma market collectively to be US$ 56 B.

  • *IQVIA MENA market report Q1 2022
  • *IQVIA Orphan & Rare disease white paper 2019
  • *The Center of Arab Genomic Studies (CAGS)